Fine tuning of 4,6-bisphenyl-2-(3-alkoxyanilino)pyrimidine focusing on the activity-sensitive aminoalkoxy moiety for a therapeutically useful inhibitor of receptor for advanced glycation end products (RAGE)

Young Taek Han(Seoul Medical Center), Young‐Ger Suh(Seoul National University), Hongchan An(Seoul National University), Jeewoo Lee(Seoul National University), Jeeyeon Lee(Seoul National University), Hyun‐Ju Park(Sungkyunkwan University), Dohyun Son(Sungkyunkwan University), Hee Yeon Kim(Medifron (South Korea)), Kyeojin Kim(Seoul National University)
Bioorganic & Medicinal Chemistry
December 8, 2014
Cited by 15


Related Papers